Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

5 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	2,092,720	2,326,368	2,654,367	2,913,241	3,539,005	3,586,214	3,351,118	3,659,250
EBITDA	347,826	271,787	393,254	432,956	507,232	446,396	373,092	413,141
Net profit	150,668	168,449	171,523	96,970	345,950	264,661	154,734	174,022
Total assets	2,120,582	2,281,349	2,723,809	2,907,339	3,146,973	3,337,403	3,544,130	2,731,775
n (companies reporting)	5	5	5	5	5	5	5	5

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Aversi-Pharma	366,150	409,571	456,542	508,166	690,807	737,781	825,680	980,306
GEPHA	450,315	518,578	614,675	679,436	782,408	789,893	823,692	861,800
Georgia Pharmacy Group	745,711	846,306	960,558	998,029	1,211,769	1,204,372	823,692	861,800
PSP Pharma	477,265	490,933	541,555	634,296	745,080	744,758	775,596	845,163
Impexpharm	53,279	60,980	81,037	93,314	108,941	109,410	102,458	110,181

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.